Nanomedicine and targeted drug delivery

Education facts

Code: 3FG025

The course provides an in-depth understanding of nanomedicine and the design of targeted drug delivery systems, with a focus on patient-centered therapies and controlled, selective drug release. You learn to analyse biological, technological, and regulatory aspects of nanotechnology-based formulations, as well as to plan, conduct, and report experimental and project-based work within the field.

Entry requirements

150 credits, with 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering, including (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Education offerings

Each offering has its own dates and conditions. Closed offerings are retained as history and do not mean that a new application is open.

• Nanomedicine and targeted drug delivery

  Uppsala University

  Start date: 1 October 2026

  End date: 1 November 2026

  Pace of study: 100 %